Dóra Koller - Concepedia

Author

Dóra Koller

Hospital Universitario de La Princesa ORCID

Also Known As

Carmen Belmonte, D E Koller, D. Koller, Dora Koller, Dóra Koller, Koller, Dora, Miriam Saiz-Rodríguez

134

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario de La Princesa Spanish Clinical Research Network Universidad Autónoma de Madrid VA Connecticut Healthcare System Yale University

About

Dóra Koller is an author at Hospital Universitario de La Princesa specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	412
2	Social Sciences	2	2	79
3	Biochemistry	2	2	112
4	Neurology	2	2	61
5	Health Sciences	1	1	22

Dóra Koller

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference Xiangrui Meng, Georgina Navoly, Olga Giannakopoulou, Nature Genetics	2024	148
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates Miriam Saiz‐Rodríguez, Susana Almenara, Marcos Navares‐Gómez, Biomedicines	2020	110
Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders Dóra Koller, Gita A. Pathak, Frank R. Wendt, JAMA Network Open	2023	105
Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications Daniel F. Levey, Marco Galimberti, Joseph D. Deak, Nature Genetics	2023	104
Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Basic & Clinical Pharmacology & Toxicology	2017	66
Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects Miriam Saiz‐Rodríguez, Dolores Ochoa, Coral Herrador, Basic & Clinical Pharmacology & Toxicology	2018	63
Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring Dóra Koller, Viktoryia Vaitsekhovich, Cecile Mba, Talanta Therapeutic Drug MonitoringBiochemistryMedicineBioanalysisEffective Quantification	2019	62
Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Basic & Clinical Pharmacology & Toxicology	2018	60
Polymorphisms in <i>CYP1A2, CYP2C9</i> and <i>ABCB1</i> affect agomelatine pharmacokinetics Miriam Saiz‐Rodríguez, Dolores Ochoa, Carmen Belmonte, Journal of Psychopharmacology	2019	53
Gene discovery and biological insights into anxiety disorders from a large-scale multi-ancestry genome-wide association study Eleni Friligkou, Solveig Løkhammer, Brenda Cabrera‐Mendoza, Nature Genetics Genome-wide Association StudyPsychiatryGeneticsBiological InsightsGenetic Epidemiology	2024	53

Page 1